血栓管理设备市场－全球产业规模、份额、趋势、机会和预测（按产品类型、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球血栓管理设备市场价值为 18.5 亿美元，预计到 2030 年将达到 24.7 亿美元，预测期内的复合年增长率为 5.11%。全球血栓管理设备市场正在稳步增长，这得益于心血管疾病、深部静脉栓塞和中风发病率的上升。这些设备在血栓的诊断、预防和治疗中起着至关重要的作用，如果不及时治疗，血栓会导致危及生命的疾病。随着医疗技术的进步，对微创手术的需求不断增加，推动了医院和门诊环境中血栓检索和抽吸设备的应用。血栓管理的技术创新，包括机械血栓切除系统和导管引导血栓溶解，正在改善临床疗效并缩短復原时间。这些发展正在提高护理标准，特别是在时间至关重要的急性缺血性中风病例中。此外，人口老化和久坐不动生活方式的日益盛行导致血栓栓塞性疾病的风险增加，进一步刺激了市场需求。例如，根据2022年4月发表的《COVID-19中的心血管疾病管理》一文，包括血栓形成在内的凝血问题已在全球范围内与COVID-19感染广泛相关。研究表明，该病毒会增加血栓栓塞併发症的风险，凸显了有效的血栓管理在治疗COVID-19患者和降低疫情期间相关心血管风险的重要性。

医疗保健提供者越来越认识到使用血栓管理设备进行早期干预的益处，这有助于减轻长期併发症的负担和医疗成本。这一趋势在拥有先进医疗基础设施的已开发地区尤为明显。同时，由于医疗保健管道的改善和人们意识的不断提高，新兴经济体也逐渐采用这些设备。支持性报销政策和正在进行的临床研究也对市场产生了影响，这些研究验证了新型血栓管理技术的安全性和有效性。然而，诸如设备成本高昂、农村地区难以获得以及对熟练专业人员的需求等挑战可能会阻碍某些地区的成长。在临床需求、技术进步以及对主动医疗干预日益增长的关注的支持下，全球血栓管理设备市场有望扩张。市场参与者可能会投资于研发，以提供创新解决方案，从而改善病患治疗效果，并满足发达和发展中医疗体系中尚未满足的医疗需求。

关键市场驱动因素

血栓栓塞性疾病盛行率上升

主要市场挑战

设备和手术成本高昂

主要市场趋势

转向微创手术

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球血块管理设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（神经血管栓塞切除装置、栓塞切除球囊导管、经皮血栓切除装置、导管定向血栓溶解装置、其他）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图
  • 依产品类型
  • 按最终用户
  • 按地区

第六章：北美血块管理设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲血块管理设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区血块管理设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲血块管理设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲血块管理设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 13 章：竞争格局

• Medtronic Plc.
• Concentric Medical, Inc.
• Boston Scientific Corporation
• Edward LifeSciences Corporation
• AngioDynamics, Inc.
• LeMaitre Vascular, Inc.
• Teleflex Incorporated
• Johnson & Johnson
• Strub Medical GmbH & Co. KG
• Cook Group Incorporated

第 14 章：策略建议

第15章调查会社について・免责事项

Global Clot Management Devices Market was valued at USD 1.85 billion in 2024 and is expected to reach USD 2.47 billion by 2030 with a CAGR of 5.11% during the forecast period. The global clot management devices market is witnessing steady growth, driven by the rising incidence of cardiovascular diseases, deep vein thrombosis, and stroke. These devices play a crucial role in the diagnosis, prevention, and treatment of blood clots that can lead to life-threatening conditions if left untreated. As medical technology advances, the demand for minimally invasive procedures is increasing, fueling the adoption of clot retrieval and aspiration devices in both hospitals and outpatient settings. Technological innovations in clot management, including mechanical thrombectomy systems and catheter-directed thrombolysis, are enhancing clinical outcomes and reducing recovery times. These developments are improving the standard of care, particularly in acute ischemic stroke cases where time is critical. Furthermore, the aging population and rising prevalence of sedentary lifestyles contribute to a higher risk of thromboembolic disorders, further boosting market demand. For instance, according to the article "Cardiovascular Disease Management in COVID-19," published in April 2022, blood coagulation issues, including clot formation, have been widely associated with COVID-19 infections worldwide. The virus has been shown to increase the risk of thromboembolic complications, highlighting the importance of effective clot management in treating COVID-19 patients and reducing related cardiovascular risks during the pandemic.

Healthcare providers are increasingly recognizing the benefits of early intervention with clot management devices to reduce the burden of long-term complications and healthcare costs. This trend is particularly evident in developed regions with advanced healthcare infrastructure. Meanwhile, emerging economies are gradually adopting these devices due to improving healthcare access and growing awareness. The market is also influenced by supportive reimbursement policies and ongoing clinical research that validates the safety and efficacy of new clot management technologies. However, challenges such as the high cost of devices, limited access in rural areas, and the need for skilled professionals may hinder growth in some regions. The global clot management devices market is poised for expansion, supported by clinical necessity, technological advancement, and a growing focus on proactive healthcare interventions. Market players are likely to invest in research and development to offer innovative solutions that improve patient outcomes and address unmet medical needs across both developed and developing healthcare systems.

Key Market Drivers

Rising Prevalence of Thromboembolic Disorders

Rising prevalence of thromboembolic disorders is one of the most significant factors propelling the growth of the global clot management devices market. For instance, the World Health Organization (WHO) estimates that by 2050, the global population aged 60 and above will reach 2.1 billion, more than doubling from 1 billion in 2020. This demographic shift highlights the growing need for age-related healthcare solutions, including advanced clot management devices.

Conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic stroke are becoming increasingly common due to lifestyle changes, aging populations, and growing rates of chronic diseases such as obesity, diabetes, and hypertension. These disorders result from the formation of blood clots that obstruct normal blood flow, posing life-threatening risks if not treated promptly. Clot management devices, including thrombectomy systems and catheter-directed thrombolysis tools, are essential for the rapid and effective removal of these clots, helping to prevent complications and reduce mortality. The sedentary nature of modern life, prolonged immobility, and increased incidences of surgical procedures contribute to higher rates of venous thromboembolism. In particular, stroke continues to be a leading cause of death and disability worldwide, placing a significant burden on healthcare systems. With early intervention proving crucial in managing thromboembolic events, hospitals and clinics are increasingly investing in advanced clot management technologies that provide quicker, safer, and more targeted treatment options. Health professionals are recognizing the importance of timely clot removal to avoid permanent damage or fatal outcomes. The growing awareness among patients and clinicians about the risks associated with untreated clots and the benefits of early treatment is leading to increased demand for these devices. This trend underscores the urgency of improving diagnostic capabilities and expanding access to life-saving clot management solutions, especially in high-risk populations.

Key Market Challenges

High Cost of Devices and Procedures

The high cost of devices and procedures is a significant challenge impacting the growth of the global clot management devices market. Advanced clot management systems, such as mechanical thrombectomy devices and catheter-directed thrombolysis tools, often come with substantial price tags. These costs extend beyond the devices themselves and include expenses related to specialized imaging equipment, procedural tools, maintenance, and skilled personnel required to operate them. Hospitals and clinics, particularly in low- and middle-income regions, may struggle to justify these investments given limited healthcare budgets and competing priorities. For patients, high treatment costs can lead to financial strain, especially in areas where health insurance coverage is insufficient or unavailable. Even in developed markets, reimbursement issues can affect both patients and healthcare providers. When coverage is limited or inconsistent, facilities may hesitate to adopt new technologies despite their clinical benefits. This reluctance can delay access to potentially life-saving treatments and contribute to disparities in care across different populations and regions. Cost challenges also impact research and development. Companies aiming to innovate must balance the need for cutting-edge features with the demand for affordability and cost-effectiveness. Striking this balance is complex and can slow down the commercialization of novel technologies. High costs may restrict the use of these devices to well-equipped urban centers, limiting availability in rural or under-resourced areas.

Addressing this challenge requires strategic pricing models, supportive reimbursement policies, and innovations focused on reducing production costs without compromising quality or performance. Lowering economic barriers is essential for expanding access and ensuring broader adoption of clot management technologies.

Key Market Trends

Shift Toward Minimally Invasive Procedures

The shift toward minimally invasive procedures is playing a critical role in driving the growth of the global clot management devices market. Traditional open surgical methods for removing clots often involve greater risk, longer hospital stays, and extended recovery periods. In contrast, minimally invasive techniques, such as catheter-directed thrombolysis and mechanical thrombectomy, offer effective treatment with reduced trauma to the body, faster patient recovery, and shorter hospitalization. These benefits make them increasingly attractive to both healthcare providers and patients. Minimally invasive procedures allow physicians to access and treat clots through small incisions or punctures, often using image-guided tools for precise navigation. This approach significantly reduces complications such as bleeding, infection, and tissue damage, which are more common in open surgeries. As a result, these procedures are being adopted widely in the management of deep vein thrombosis, pulmonary embolism, and ischemic stroke. Healthcare systems are also recognizing the economic advantages of these procedures. Shorter recovery times translate to lower hospital costs, quicker patient turnover, and better resource allocation. In many cases, patients can be treated in outpatient or ambulatory care settings, reducing the burden on hospitals and improving accessibility.

Medical device manufacturers are responding to this trend by developing compact, user-friendly devices that support rapid intervention and high procedural success rates. As patient demand grows for less invasive treatment options, and as medical professionals seek efficient and safe alternatives to surgery, the market for minimally invasive clot management devices is expected to expand significantly in both developed and emerging healthcare settings.

Key Market Players

• Medtronic Plc.
• Concentric Medical, Inc.
• Boston Scientific Corporation
• Edward LifeSciences Corporation
• AngioDynamics, Inc.
• LeMaitre Vascular, Inc.
• Teleflex Incorporated
• Johnson & Johnson
• Strub Medical GmbH & Co. KG
• Cook Group Incorporated

Report Scope:

In this report, the Global Clot Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clot Management Devices Market, By Product Type:

• Neurovascular Embolectomy Devices
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter Directed Thrombolysis Devices
• Others

Clot Management Devices Market, By End User:

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

Clot Management Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clot Management Devices Market.

Available Customizations:

Global Clot Management Devices Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clot Management Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map
  • 5.3.1. By Product Type
  • 5.3.2. By End User
  • 5.3.3. By Region

6. North America Clot Management Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clot Management Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Mexico Clot Management Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Canada Clot Management Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End User

7. Europe Clot Management Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Clot Management Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Clot Management Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Clot Management Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Clot Management Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Clot Management Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Clot Management Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Clot Management Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Clot Management Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End User
  • 8.3.3. South Korea Clot Management Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Japan Clot Management Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Clot Management Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End User

9. South America Clot Management Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Clot Management Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Clot Management Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Clot Management Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Clot Management Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Clot Management Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Clot Management Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Clot Management Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Medtronic Plc.
• 13.2. Concentric Medical, Inc.
• 13.3. Boston Scientific Corporation
• 13.4. Edward LifeSciences Corporation
• 13.5. AngioDynamics, Inc.
• 13.6. LeMaitre Vascular, Inc.
• 13.7. Teleflex Incorporated
• 13.8. Johnson & Johnson
• 13.9. Strub Medical GmbH & Co. KG
• 13.10. Cook Group Incorporated

14. Strategic Recommendations

15. About Us & Disclaimer